FTSE MIB
33.395,44 -558,84 (-1,65%) Dow Jones
37.735,11 -248,13 (-0,65%) Nasdaq
15.885,02 -290,08 (-1,79%) Nikkei 225
38.471,20 -761,60 (-1,94%) Petrolio
85,04 -0,37 (-0,43%) Bitcoin EUR
58.922,07 -3.697,01 (-5,90%)
Intuitive Surgical, Inc. (ISRG.MX)
| Chiusura precedente | 6.432,00 |
| Aperto | 0,00 |
| Denaro | 6.432,00 x 0 |
| Lettera | 7.000,00 x 0 |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 409 |
| Capitalizzazione | 2,28T |
| Beta (5 anni mensile) | 1,38 |
| Rapporto PE (ttm) | 76,92 |
| EPS (ttm) | 83,62 |
| Prossima data utili | 16 apr 2024 - 22 apr 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireIntuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2023. Q2 Highlights Worldwide da Vinci procedures grew approximately 22% compared with the second quarter of 2022. During the second quarter of 2022, the Company’s procedure volumes were negatively impacted by COVID-19 cases and increased ho
- GlobeNewswire
Intuitive Announces Executive Leadership Changes
Dave Rosa named President; Gary Guthart remains Chief Executive OfficerSUNNYVALE, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced executive leadership changes as the company continues expanding globally and advancing minimally invasive care. Dave Rosa has been promoted to the role of President, leading Intuitive’s product, digital, quality, regulatory, supply chai
- GlobeNewswire
Intuitive receives FDA clearance of da Vinci SP for simple prostatectomy
SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and pioneer of robotic-assisted surgery, announced that the Food and Drug Administration recently cleared the da Vinci SP surgical system for simple prostatectomy as a representative procedure, which expands the urologic surgical procedures cleared by FDA. Simple prostatectomy is a surgical procedure often used in patients with benign prostatic hyperplasia (BPH) o
